Insider Trading History of Smith Alan E

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Smith Alan E since 2007. The trader's CIK number is 1021037. At the time of the last reporting, Smith Alan E was the Sr VP,Chief Scientif of Genzyme Corp. (stock ticker symbol GENZ). Also see all insider trading activities at Genzyme Corp.


Yearly summary of insider trading at Genzyme Corp (GENZ) by Smith Alan E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 GENZ 0 $0 0 $0 7,815 $0
2010 GENZ 0 $0 23,497 $1,259,269 29,485 $427,948
2009 GENZ 0 $0 2,694 $161,101 2,694 $0
2008 GENZ 0 $0 116,737 $8,492,174 98,282 $2,939,621
2007 GENZ 0 $0 20,000 $1,500,000 20,000 $588,800


Insider trading of Genzyme Corp (GENZ) by Smith Alan E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-04-04 GENZ Option Ex 7,815 .00 0
2010-05-27 GENZ Sale 1,737 49.54 86,050
2010-05-25 GENZ Sale 4,789 45.62 218,498
2010-05-22 GENZ Option Ex 2,694 .00 0
2010-05-24 GENZ Option Ex 8,083 .00 0
2010-05-21 GENZ Sale 822 48.93 40,220
2010-05-21 GENZ Option Ex 2,559 .00 0
2010-03-04 GENZ Option Ex 16,149 26.50 427,948
2010-03-04 GENZ Sale 16,149 56.63 914,501
2009-06-02 GENZ Sale 1,809 61.40 111,065
2009-05-22 GENZ Option Ex 2,694 .00 0
2009-05-26 GENZ Sale 885 56.54 50,036
2008-12-08 GENZ Sale 55,521 65.17 3,618,303
2008-12-08 GENZ Option Ex 55,521 29.44 1,634,538
2008-08-14 GENZ Option Ex 15,000 32.52 487,800
2008-08-14 GENZ Sale 15,000 82.51 1,237,650
2008-08-05 GENZ Option Ex 27,761 29.44 817,283
2008-08-05 GENZ Sale 27,761 78.00 2,165,358
2008-07-15 GENZ Sale 18,455 79.70 1,470,863
2007-12-17 GENZ Option Ex 20,000 29.44 588,800
2007-12-17 GENZ Sale 20,000 75.00 1,500,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Alan E (Sr VP,Chief Scientif of Genzyme Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.